Skip to content

Income Tax at other companies

Revvity logo
RevvityRVTY
$9.1M-15.1%
Incyte logo
IncyteINCY
$40.27M-47.0%
Gilead Sciences logo
Gilead SciencesGILD
$559M+67.4%
AbbVie logo
AbbVieABBV
$342M-8.1%
Moderna logo
ModernaMRNA
$9M+28.6%
Biogen logo
BiogenBIIB
$58.2M-17.7%

Segments

By segment

See full
Reportable Segment$5.51M-29.9%

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s income tax?
Krystal Biotech, Inc. (KRYS) reported income tax of $5.51M in Q1 2026.
How has Krystal Biotech, Inc.'s income tax changed year-over-year?
Krystal Biotech, Inc.'s income tax decreased by 29.9% year-over-year, from $7.86M to $5.51M.
What does income tax mean?
The total amount of income tax the company is required to pay for the period.
How do you interpret income tax?
An increase may indicate higher profitability or changes in tax legislation, while a negative value often reflects a tax benefit or credit realization.
How does income tax compare across companies?
Standard across all public companies; varies based on effective tax rates and jurisdictional tax laws.